Form 4: Xtant Medical Holdings COO Receives Stock Grant
Insider Transaction (Form 4)
Mark A. Schallenberger, Chief Operating Officer of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.
Summary
- Grant/award: acquired 450,000 Common Stock on August 15, 2026; holds 1,113,157 after (Direct).
- Tax/exercise-price withholding: disposed of 7,070 Common Stock at $0.31 ($2,192) on August 15, 2026; holds 1,106,087 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark A. Schallenberger — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Grant/award | Common Stock | 450,000 | — | — | 1,113,157 |
| 2026-08-15 | Tax/exercise-price withholding | Common Stock | 7,070 | $0 | $2.2K | 1,106,087 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Grant/award (450,000 shares) |
| 2026-08-15 | Tax/exercise-price withholding (7,070 shares) |
Keywords
insider transaction, Form 4, XTNT, Xtant Medical Holdings, Inc., neutral, Mark A. Schallenberger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.